Together, we make a difference
Here's to 25 years of achievements, innovation, and
collaboration. Together, we continue to make a difference for patients around the world.
We are committed to developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with severe and life-threatening bacterial and fungal infections. Basilea is located in the Basel area, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN).
Highlights Full-Year report
"Our goal is to become a leading anti-infectives company and serve patients around the world."
News
Full-Year Report 2025
People are at the heart of everything we do.
CEO Statement
For the benefit of patients around the world, we are continuing to establish Cresemba and Zevtera as truly global brands. Based on our proven expertise in advancing anti-infectives through research and development to the market, we are aiming at becoming a leading anti-infectives company.
